IFNA6 - interferon alpha 6 Gene
Also Known as IFN-alphaK
Species: Homo sapiens
About IFNA6
This gene has 2 transcripts (splice variants), 585 orthologues and 16 paralogues.
Summary
Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Biomarker of anogenital venereal wart. [provided by Alliance of Genome Resources, Apr 2022]
IFNA6 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_021002.2 | NP_066282.1 | interferon alpha-6 precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
32296183 | GOA |
IFNA6 Protein Structure
Interferon: Interferon alpha/beta domain (26 - 187)
- 0
- 100
- 189 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
interferon alpha-6 |
|
IFNA6 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
IFNA6 | P05013 | MEOX2 | Homo sapiens | Q6FHY5 | 32296183 | |
|
Intra
|
IFNA6 | P05013 | MEOX2 | Homo sapiens | Q6FHY5 | 32296183 | |
|
Intra
|
IFNA6 | P05013 | MEOX2 | Homo sapiens | Q6FHY5 | 32296183 |
Recombinant IFNA6 Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P72244 | IFN-alpha 6/IFNA6 Protein, Human (His-Myc) | P05013 (S21-E189) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P72614 | IFN-alpha 6/IFNA6 Protein, Human (HEK293, His) | P05013 (S21-E189) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Multisystem Inflammatory Syndrome In Children |
|
|
| Anogenital Venereal Wart |
|
|
| X-Linked Immunodeficiency 74 |
|
|